Loading clinical trials...
Loading clinical trials...
Eight patients with corneal neovascularization were treated with subconjunctival injection of 1.25 mg bevacizumab and had a follow-up of at least 2 months. All patients had persistent corneal neovascu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Instituto de Olhos de Goiania
NCT04787471 · Corneal Neovascularization
NCT00555594 · Corneal Neovascularization
NCT05659940 · Corneal Neovascularization, Neutrophils
NCT00559936 · Corneal Neovascularization
NCT02797704 · Corneal Neovascularization
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions